苑东生物(688513.SH)：上半年净利润1.37亿元，同比下降6.77%

Core Viewpoint - Yuan Dong Bio (688513.SH) reported a decline in both revenue and net profit for the first half of 2025, primarily due to the implementation of the tenth batch of national centralized procurement and increased stock incentive expenses [1] Financial Performance - The company achieved operating revenue of 654 million yuan, a year-on-year decrease of 2.25% [1] - Net profit attributable to shareholders was 137 million yuan, down 6.77% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 104 million yuan, reflecting an 8.68% year-on-year decline [1] - Basic earnings per share stood at 0.77 yuan [1]